These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17280507)
1. State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma. Bermudez RS; Izaguirre A; Roach M Future Oncol; 2007 Feb; 3(1):103-11. PubMed ID: 17280507 [TBL] [Abstract][Full Text] [Related]
2. Controversies in prostate cancer radiotherapy: consensus development. Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L; Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy in the management of clinically localized prostate cancer: evolving standards, consensus, controversies and new directions. Speight JL; Roach M J Clin Oncol; 2005 Nov; 23(32):8176-85. PubMed ID: 16278470 [TBL] [Abstract][Full Text] [Related]
4. The current status of image-guided external beam radiotherapy for prostate cancer. Stephans KL; Xia P; Tendulkar RD; Ciezki JP Curr Opin Urol; 2010 May; 20(3):223-8. PubMed ID: 20179597 [TBL] [Abstract][Full Text] [Related]
5. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how? Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic innovations in radiation oncology for localized prostate cancer]. Créhange G; Cormier L Cancer Radiother; 2017 Oct; 21(6-7):454-461. PubMed ID: 28890087 [TBL] [Abstract][Full Text] [Related]
7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
8. Contemporary issues in radiotherapy for clinically localized prostate cancer. Khor R; Williams S Hematol Oncol Clin North Am; 2013 Dec; 27(6):1137-62, vii. PubMed ID: 24188256 [TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy: a significant treatment option in management of prostatic cancer]. Ohara K Gan To Kagaku Ryoho; 1998 May; 25(6):823-8. PubMed ID: 9617320 [TBL] [Abstract][Full Text] [Related]
11. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433 [TBL] [Abstract][Full Text] [Related]
12. Update on radiation therapy in prostate cancer. Lee AK; Frank SJ Hematol Oncol Clin North Am; 2006 Aug; 20(4):857-78. PubMed ID: 16861119 [TBL] [Abstract][Full Text] [Related]
13. PET/CT and radiotherapy in prostate cancer. De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021 [TBL] [Abstract][Full Text] [Related]
14. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond]. Teh BS; Paulino A; Butler EB Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628 [TBL] [Abstract][Full Text] [Related]
15. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy. Speight JL; Roach M J Clin Oncol; 2007 Mar; 25(8):987-95. PubMed ID: 17350948 [TBL] [Abstract][Full Text] [Related]
17. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Court LE; Dong L; Lee AK; Cheung R; Bonnen MD; O'Daniel J; Wang H; Mohan R; Kuban D Int J Radiat Oncol Biol Phys; 2005 May; 62(1):154-63. PubMed ID: 15850916 [TBL] [Abstract][Full Text] [Related]
19. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723 [TBL] [Abstract][Full Text] [Related]
20. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]